First-Half 2015 Business Review

Strong growth in business
- €933 million in sales
- Up 19.5% as reported
- Up 8.1% like-for-like
Fast-rising sales in the Americas, up 18.3%, and a return to more sustained expansion in the Asia-Pacific, up 6.6%
Robust demand in the priority areas for growth
- FilmArray® sales doubled year-on-year, installed base expanded to nearly 1,900 instruments
- Solid 5.0% gain in clinical microbiology
- Sustained 7.4% improvement in VIDAS® sales
- Satisfactory 4.4% growth in industrial applications
Alexandre Mérieux, Chief Executive Officer, said: "In the first half of 2015, bioMérieux delivered a fast 8.1% increase in sales on a like-for-like basis. The first six months attest to continued strong sales momentum in North America and robust performances in our main strategic businesses. In particular, FilmArray® continued to demonstrate remarkable success by doubling its sales over the period. It once again fulfilled its role as a driver of faster growth for the Group and strengthened its leadership in the syndromic diagnosis of infectious diseases. The period saw signs of a gradual return to more energetic growth in China. As a result, we are confirming the 2015 organic sales growth objective set earlier this year."